Peripheral infectious keratitis

Authors

  • G.I. Drozhzhyna State Institution “The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine”, Odesa, Ukraine
  • K.V. Sereda State Institution “The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine”, Odesa, Ukraine

DOI:

https://doi.org/10.22141/2309-8147.8.2.2020.209921

Keywords:

infectious peripheral keratitis, infiltrate, phlycten, blepharitis, corneal ulcer, combination drug

Abstract

Peripheral keratitis (PK) is a group of destructive inflammatory diseases of the juxtalimbal corneal stroma that are associated with an epithelial defect, the presence of inflammatory cells in the stroma, and progressive destruction of the corneal stroma. The causes of PK may be as follows: pathology of the eyelids and skin diseases, systemic infectious diseases, as well as a number of non-infectious immune disorders and diffuse connective tissue diseases. The clinical picture of peripheral infectious keratitis (PIK) is characterized by the formation of infiltrates on the periphe­ry of the cornea and the formation of crescent-shaped ulcerations of the cornea. PIK are most common in inflammatory diseases of the conjunctiva, the edges of the eyelids (in seborrheic blepharitis, staphylococcal blepharitis, and rosacea). Differential diagnosis of PIK must be performed with keratitis in case of systemic connective tissue diseases, marginal keratitis in case of lagophthalmos, Mooren’s ulcer, autoimmune diseases of the body involving the mucous membranes and surface of the eye in the pathological process. The main principles of PIC treatment are finding out the cause, controlling the inflammatory process and stimulating corneal regeneration. In the comprehensive therapy for PIK, antibiotics, collagenase inhibitors, reparative drugs, artificial tears, mydriatics are used, as well as combination drugs, which include a bactericidal antibiotic and a corticosteroid. For the treatment of PK associated with the disease of the edges of the eyelids and skin, a combination of antibacterial and glucocorticoid drugs is necessary with control of the underlying disease.

References

Sharma N., Sinha G., Shekhar H., Titiyal J.S. et al. Demogra­phic profile, clinical features and outcome of peripheral ulcerative keratitis: a prospective study. Br. J. Ophthalmol. 2015. 99 (11). 1503-1508.

Бржеский В.В., Сомов Е.Е. Клиническая диагностика и лечение больных с сухим кератоконъюнктивитом на почве синдрома Съегрена. Офтальмохирургия и терапия. 2001. 1 (1). 42-46.

Груша Я.О., Исмаилова Д.С., Новиков П.И., Абрамова Ю.В. Офтальмологические проявления гранулематоза с полиангиитом (гранулематоз Вегенера). Терапевтический архив. 2015. 87 (12). 111-116.

Тарасова Л.Н., Кудряшова Ю.И. Особенности клиники синдрома «сухого глаза» при системных аутоиммунных заболеваниях. Офтальмология. 2007. 4 (2). 52-58.

Gregory J.K., Foster C.S. Peripheral ulcerative keratitis in the collagen vascular diseases. Int. Ophthalmol. Clin. 1996. 36 (1). 21-30.

Рикс И.А., Ткаченко Н.В. К вопросу о дифференциальной диагностике болезни Мурена и болезни Терриена. Офтальмологические ведомости. 2008. 1 (2). 77-83.

Smith V.A., Hoh H.B. Role of ocular matrix metalloproteina­ses in Peripheral Ulcerative Keratitis. Br. J. Ophthalmol. 1999. 83. 1376-1383.

Messmer E.M., Foster C.S. Vasculitic peripheral ulcerative keratitis. Surv. Ophthalmol. 1999. 43 (5). 379-396.

Uveitis and immunological disorders. Ed. Pleyer U., Foster C.S. Springer. 2007. 274 р.

Nakao S., Hafezi-Moghadam A., Ishibashi T. Lymphatics and lymphangiogenesis in the eye. J. Ophthalmol. 2012. 763-783.

Степанов В.К., Муриева И.В., Исаева О.В. Лечебная пересадка роговицы при деструктивной кератопатологии у больных ревматоидным полиартритом. Вестник Оренбургского государственного университета. 2015. 187. 231-233.

Knox Cartwright N.E., Tole D.M., Georgoudis P., Cook S.D. Peripheral ulcerative keratitis and corneal melt. a 10-year single center review with historical comparison. Cornea. 2014. 33 (1). 27-31.

Дроздова Е.А., Тимошевская Е.И. Дифференциальная диагностика и тактика лечения периферических поражений роговицы. Точка зрения. Восток — Запад. 2017. № 1. С. 57-60.

Lemp M.A., Nichols K.K. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul. Surf. 2009. 7 (suppl. 2). Р1 S14.

Дрожжина Г.И. Воспалительные заболевания век. Одесса: Астропринт, 2011. 86 с.

Chranioti A., Malamas A. Bilateral Herpes Simplex Virus-related Peripheral Ulcerative Keratitis Leading to Corneal Perforation in a Patient with Primary Herpes Simplex Virus Infection. J. Ophthalmic. Vis. Res. 2019 Jan-Mar. 14 (1). 93-96.

Trufanov S.V., Krakhmaleva D.A. Mushroom keratoplasty in rosacea keratitis complicated by corneal perforation (a clinical case). Vestn. Oftalmol. 2019. 135 (5. Vyp. 2). 215-219.

Dong Y.L., Zhang Y.Y. Clinical features, treatment distribution and outcomes of Mooren's ulcer. Zhonghua Yan Ke Za Zhi. 2019 Feb. 11. 55.(2). 127-133.

Published

2020-03-01

Issue

Section

Exchange of Experience